Supernus Pharmaceuticals, Inc.
SUPN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001356576
No open-market purchases or sales by Supernus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 334 institutions reported holding it in 13F filings for Q2 2026, worth $2.80B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Supernus Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 244
- +20 vs. Q2 2022
- Shares held
- 55.7M
- +911.2K (+1.7%) vs. Q2 2022
- Total value
- $1.88B
- +$300.6M (+19.0%) vs. Q2 2022
- New holders
- 39
- 91 more added
- Sold out
- 19
- 76 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SUPN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 334 | $2.80B |
| Q1 2026 | 328 | $3.01B |
| Q4 2025 | 333 | $2.84B |
| Q3 2025 | 310 | $2.76B |
| Q2 2025 | 295 | $1.87B |
| Q1 2025 | 295 | $1.94B |
| Q4 2024 | 294 | $2.15B |
| Q3 2024 | 273 | $1.87B |
| Q2 2024 | 245 | $1.56B |
| Q1 2024 | 251 | $1.93B |
| Q4 2023 | 245 | $1.65B |
| Q3 2023 | 239 | $1.57B |
| Q2 2023 | 249 | $1.72B |
| Q1 2023 | 259 | $2.01B |
| Q4 2022 | 264 | $1.99B |
| Q3 2022 | 244 | $1.88B |
| Q2 2022 | 225 | $1.58B |
| Q1 2022 | 230 | $1.75B |
| Q4 2021 | 235 | $1.61B |
| Q3 2021 | 224 | $1.45B |
| Q2 2021 | 226 | $1.67B |
| Q1 2021 | 224 | $1.40B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Supernus Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 210,406 | $7.12M | 0.00% | −42,689−16.9% | Reduced |
| Goldman Sachs Group Inc | 221,732 | $7.51M | 0.00% | −85,751−27.9% | Reduced |
| SEI Investments Co | 244,521 | $8.28M | 0.02% | +18,127+8.0% | Added |
| Emerald Mutual Fund Advisers Trust | 273,568 | $9.26M | 0.59% | +212,873+350.7% | Added |
| International Biotechnology Trust PLC | 297,500 | $10.1M | 3.23% | +288,896+3,357.7% | Added |
| S&T Bank | 301,226 | $10.2M | 1.97% | −12,164−3.9% | Reduced |
| Citadel Advisors LLC | 309,691 | $10.5M | 0.01% | +216,771+233.3% | Added |
| Scout Investments, Inc. | 312,617 | $10.6M | 0.22% | −8,816−2.7% | Reduced |
| Emerald Advisers, LLC | 313,477 | $10.6M | 0.55% | +243,577+348.5% | Added |
| Mesirow Institutional Investment Management, Inc. | 325,085 | $11.0M | 1.60% | +325,085 | New |
| Bank of America Corp | 335,093 | $11.3M | 0.00% | +12,148+3.8% | Added |
| Principal Financial Group Inc | 342,860 | $11.6M | 0.01% | −23,531−6.4% | Reduced |
| Tributary Capital Management, LLC | 355,024 | $12.0M | 1.26% | −5,459−1.5% | Reduced |
| Nuveen Asset Management, LLC | 373,509 | $12.6M | 0.01% | +18,950+5.3% | Added |
| Mutual of America Capital Management LLC | 374,901 | $12.7M | 0.17% | −7,843−2.0% | Reduced |
| Lisanti Capital Growth, LLC | 383,180 | $13.0M | 1.73% | −33,470−8.0% | Reduced |
| Norges Bank | 428,573 | $14.5M | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 467,774 | $15.8M | 0.01% | +38,323+8.9% | Added |
| Epoch Investment Partners, Inc. | 491,240 | $16.6M | 0.11% | +15,199+3.2% | Added |
| Congress Asset Management Co | 507,463 | $17.2M | 0.18% | +25,921+5.4% | Added |
| Price T Rowe Associates Inc | 507,863 | $17.2M | 0.00% | −885−0.2% | Reduced |
| Morgan Stanley | 515,734 | $17.5M | 0.00% | +41,705+8.8% | Added |
| Bank of New York Mellon Corp | 521,227 | $17.6M | 0.00% | +9,723+1.9% | Added |
| Invesco Ltd. | 634,429 | $21.5M | 0.01% | −47,887−7.0% | Reduced |
| Rice Hall James & Associates, LLC | 679,311 | $23.0M | 1.33% | −154,641−18.5% | Reduced |
| Northern Trust Corp | 690,583 | $23.4M | 0.01% | −748−0.1% | Reduced |
| Frontier Capital Management Co LLC | 702,808 | $23.8M | 0.28% | +86,433+14.0% | Added |
| Victory Capital Management Inc | 777,469 | $26.3M | 0.03% | −7,251−0.9% | Reduced |
| Ameriprise Financial Inc | 793,557 | $26.9M | 0.01% | −31,503−3.8% | Reduced |
| Woodline Partners LP | 793,767 | $26.9M | 0.39% | +225,188+39.6% | Added |
| Polar Capital Holdings Plc | 794,120 | $26.9M | 0.22% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 948,910 | $32.1M | 0.00% | +9,769+1.0% | Added |
| Ashford Capital Management Inc | 1,094,443 | $37.0M | 5.65% | −34,984−3.1% | Reduced |
| Aristotle Capital Boston, LLC | 1,157,553 | $39.2M | 1.32% | −110,187−8.7% | Reduced |
| Renaissance Technologies LLC | 1,280,222 | $43.3M | 0.06% | −116,800−8.4% | Reduced |
| Loomis Sayles & Co L P | 1,601,303 | $54.2M | 0.11% | −9,659−0.6% | Reduced |
| Stephens Investment Management Group LLC | 1,605,806 | $54.4M | 1.03% | −6,576−0.4% | Reduced |
| GW&K Investment Management, LLC | 1,767,489 | $59.8M | 0.66% | −142,360−7.5% | Reduced |
| State Street Corp | 1,923,295 | $65.1M | 0.00% | −54,886−2.8% | Reduced |
| Dimensional Fund Advisors LP | 2,270,480 | $76.9M | 0.03% | +31,355+1.4% | Added |
| Macquarie Group Ltd | 2,370,120 | $80.2M | 0.10% | +32,816+1.4% | Added |
| Armistice Capital, LLC | 4,593,004 | $155.5M | 3.91% | −118,996−2.5% | Reduced |
| Vanguard Group Inc | 5,680,242 | $192.3M | 0.01% | +59,794+1.1% | Added |
| BlackRock Inc. | 9,216,574 | $312.0M | 0.01% | +420,429+4.8% | Added |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Equity & Fixed Income | 0 | $0 | 0.00% | −398,885−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −258,100−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −244,223−100.0% | Sold out |
| Aurora Investment Counsel | 0 | $0 | 0.00% | −41,668−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −33,208−100.0% | Sold out |
| SummerHaven Investment Management, LLC | 0 | $0 | 0.00% | −33,123−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −23,643−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −23,262−100.0% | Sold out |
| Maryland State Retirement & Pension System | 0 | $0 | 0.00% | −21,750−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −12,919−100.0% | Sold out |
| CWM Advisors, LLC | 0 | $0 | 0.00% | −7,349−100.0% | Sold out |
| Quent Capital, LLC | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −825−100.0% | Sold out |
| Patriot Financial Group Insurance Agency, LLC | 0 | $0 | 0.00% | −652−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −170−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Elequin Capital LP | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Sageworth Trust Co of South Dakota | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Private Capital Group, LLC | – | – | – | – | Not filed |